Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Repeated may slow repair by doubling without

Repeated may leave surviving and some with extra copies, increasing while slowing repair. No accumulated increase in copies, or continued functional decline after preventing it, would refute the hypothesis.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

The biological function description is being prepared

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Genome dosage geometry
Goal
Определение терапии с полным и устойчивым восстановлением функций кожи
Competing hypotheses
2
Published
2026-09-25
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
7 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Rhythm or programme

    Polyploidization

    An increase in the number of copies within a cell

    Where this hypothesis actsSurviving and some after repeated

    Hypotheses on this target 2
    PolyploidizationInhibition. Hypotheses on this target 22Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition2
    • Activation
    • Function preservation
    • Feedback restoration
    • Rhythm restoration
    • Direct measurement

    What is proposed

    Inhibition

    Prevent repeated duplication without

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible preservation of barrier repair, mechanical recovery and despite reduced gain

    From the recordПредотвращение повторной полиплоидизации должно стабилизировать SPV_9, даже если прирост коллагена уменьшится.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionPolyploidization. Hypotheses on this target 2Polyploidization
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin can produce more structural material without necessarily recovering its ability to withstand everyday wear. The unexpected proposal is that repeated injuries leave surviving cells larger and carrying extra copies of their genetic material, making them productive but less able to move and rebuild tissue. This is a hypothesis generated by the pipeline, not a measured result of repeated skin treatments.

The proposed mechanism, link by link
  1. Repeated small-zone injuries are proposed to shift surviving repair cells from copying genetic material and dividing to copying it repeatedly without dividing.
  2. Extra genetic sets are proposed to enlarge those cells while leaving their material production high.
  3. The enlarged cells are proposed to move and rearrange less effectively, allowing accumulation to coexist with slower repair.
  4. Their altered size is proposed to disrupt rebuilding of the outer skin layer and the supporting layer around growing nerve endings.
  5. Persistent changes in the same cells and their descendants are proposed to carry the impairment into later injury cycles.
  6. Preventing further accumulation of genetic sets is predicted to preserve recovery of protection, mechanical properties and nerve supply, even with less gain.
A picture for it

A repair crew could keep making bricks while becoming less able to move around the site and put them in the right places. A growing pile of bricks would then coexist with slower rebuilding.

Where the picture breaks: Cells also divide, signal to one another and interact with nerves. The picture illustrates the proposed separation between production and repair; it does not establish that extra genetic material causes reduced movement.

  1. Master questionstep 01 of 04

    A therapy should restore the functioning of middle-aged human skin to that of young skin.

    Rests on: The supplied goal explicitly seeks younger skin function, rather than specifying appearance as the outcome.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Restoration of skin function should be complete and sustained.

    Rests on: The original goal seeks the functional condition of young skin.

    Assumption

    This stage treats the goal as requiring complete and lasting restoration; the original wording does not specify completeness or duration.

  3. Gap questionstep 03 of 04

    Repeated , which injure small zones within the treated skin, might exhaust its capacity to repair even while , a structural protein, increases. The proposed warning is progressively slower recovery of the protective barrier, strength and sensation after the same everyday challenge.

    Rests on: A requirement for sustained function makes recovery after repeated challenges relevant.

    Leap

    The preceding goal does not supply a reason to single out repeated , or establish that slowing recovery measures exhaustion of repair capacity. Those connections remain questions in the supplied chain.

  4. Hypothesisstep 04 of 04

    Repeated injuries are proposed to make , cells that produce skin's supporting material, and some , cells in the bottom layer of its outer covering, repeatedly copy their genetic material without dividing. The resulting , which carry extra complete sets of genetic material, are proposed to enlarge and keep producing material while losing the movement and rearrangement needed for repair.

    Rests on: The preceding question identifies a possible separation between accumulation and functional recovery, but does not identify its cause.

    Leap

    Neither the preceding stage nor the screened evidence establishes the required connection from repeated to accumulating extra genetic sets in these cells, followed by impaired movement and functional recovery. The missing connection concerns the stated mechanism, not the fact that it is an untested proposal.

What is carried, and what is not. The supplied excerpt from S3, The Journal of Biological Chemistry (2015), supports one narrow link: cells producing supporting material beneath the skin acquired doubled genetic content after failed division during wound healing, but this involved genetically altered mice with one wound through the full skin thickness, not repeated or the proposed functional outcomes. The abstract of S8, Molecular & General Genetics (1987), instead reports lower production in human cells from spontaneous pregnancy losses with certain extra , the structures carrying genetic material, or an extra complete set; those developmental abnormalities do not settle acquired changes after adult skin injury, and neither source establishes the proposed sequence end to end.S3S8

Where the reasoning is carried by something unstated · 3
  • Goal pillar. This stage treats the goal as requiring complete and lasting restoration; the original wording does not specify completeness or duration.
  • Gap question. The preceding goal does not supply a reason to single out repeated , or establish that slowing recovery measures exhaustion of repair capacity. Those connections remain questions in the supplied chain. Establish the missing link before relying on this step.
  • Hypothesis. Neither the preceding stage nor the screened evidence establishes the required connection from repeated to accumulating extra genetic sets in these cells, followed by impaired movement and functional recovery. The missing connection concerns the stated mechanism, not the fact that it is an untested proposal. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A higher amount of genetic material per cell could be mistaken for persistent accumulation of extra sets when it reflects ordinary preparation for division. Cells with multiple nuclei, the compartments containing genetic material, could also be counted as though they represented the same process. What closes it: The proposed measurements must combine genetic-content imaging, measurements and observation through the division cycle in tracked cells and their descendants. The distinction between temporary doubling, persistent extra sets and multiple nuclei must be fixed before interpreting the results.
  • Improved recovery after an intervention could be credited to preventing extra genetic sets even if the intervention instead reduces the original injury or changes cell survival and number. Conversely, continued deterioration would not refute the mechanism if the intervention failed to prevent the targeted accumulation. What closes it: The intervention must demonstrably prevent repeated genetic doubling without division while initial injury, cell survival and cell number remain comparable. The supplied specification says that this selective intervention still requires development; broadly slowing is insufficient.
  • Failure of restored nerve activity or spatial repair signals to rescue recovery could be read as excluding the rivals even if the alternative treatment never restored the process its rival requires. Nerve activity alone is not the same as completed regrowth of nerve connections. What closes it: A comparison must verify restoration of the relevant spatial signals or nerve connections before interpreting an incomplete rescue. Sensation requires a model with functioning nerve supply, as the specification states, and must be assessed alongside barrier and mechanical recovery.

What would make this wrong. The proposed explanation would fail if recovery progressively worsened without persistent accumulation of extra complete genetic sets in the tracked repair cells, or if a verified selective intervention prevented that accumulation but recovery still deteriorated under comparable injury, cell survival and cell number. Complete rescue by restored spatial signals or nerve function while the extra genetic sets remained would also contradict the hypothesis's stated distinguishing prediction.

What it would change. If the mechanism held, progress toward youthful skin function would require checking whether repeated treatment preserves later repair capacity, alongside measuring . Preventing persistent changes in repair cells could become a candidate component of therapy. Even a successful model test would not establish complete, sustained restoration in middle-aged humans; the supplied material gives no treatment schedule, duration of benefit or definition of the outcome code .

Sources read · 7

4 literature searches, 7 full texts, 3 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Contradicts itAbstract only

Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. · Journal of cell science · 2005

“The skin is tight and fragile, tears off in areas of mechanical friction and displays impaired wound healing. Steady-state epidermis is thinner, with loss of the proliferative compartment and premature differentiation. Remarkably, keratinocyte cell size, growth and endoreplication are reduced, and stem cell amplification is compromised.”

Does not settle: This abstract describes epidermis-specific Myc knockout mice, not repeated fractional injury. It does not assess fibroblasts, increased polyploidization, collagen accumulation, keratinocyte migration, dermal organization, nerve endings, SPV_9, or whether preventing repeat polyploidization improves repair.

S2Contradicts itAbstract only

Different cell cycle responses of wound healing protagonists to transient in vitro hypoxia. · Histochemistry and cell biology · 2005

“NHDF did not generate any polyploid cells, which stands in contrast to former in vitro studies with human wound-derived fibroblasts, but HDMEC were characterized by the presence of both mononuclear and binuclear tetraploid cells.”

Does not settle: Абстракт описывает нормальные дермальные фибробласты человека и эндотелиальные клетки в условиях 18 часов гипоксии с последующей реоксигенацией in vitro. Он не устанавливает последствия повторных фракционных повреждений, данные о базальных кератиноцитах, миграции, синтезе и накоплении коллагена, восстановлении эпидермиса и дермы, нервных окончаниях, последовательной полиплоидизации или SPV_9.

S3Partly answers it

Cytokinetic Failure-induced Tetraploidy Develops into Aneuploidy, Triggering Skin Aging in Phosphovimentin-deficient Mice. · The Journal of biological chemistry · 2015

“Early into wound healing, subcutaneous fibroblasts failed to undergo cytokinesis, resulting in binucleate tetraploidy.”

Does not settle: Работа описывает один полнослойный кожный дефект у мышей с дефицитом фосфовиментина. Она не устанавливает эффект повторных фракционных повреждений, участие базальных кератиноцитов, последовательные циклы удвоения генома, синтетическую активность, миграцию, накопление коллагена, организацию дермы вокруг нервных окончаний, SPV_9 или эффект предотвращения полиплоидизации.

S4Partly answers it

Abnormal proliferation and aging of cultured fibroblasts from pigs with subcutaneous fibrosis induced by gamma irradiation. · The Journal of investigative dermatology · 1989

“Cell morphology and the number of chromosomes were modified throughout subcultures.”

Does not settle: Остаются открытыми повторные фракционные повреждения, удвоение генома без деления, полиплоидия, кератиноциты, миграция, организация дермы, скорость функционального ремонта и влияние предотвращения полиплоидизации на SPV_9.

S7Background

Dual role of FGF in proliferation and endoreplication of Drosophila tracheal adult progenitor cells. · Journal of molecular cell biology · 2020

“Bnl/Fgf signaling pathway promotes endoreplication in SB differentiated cells”

Does not settle: This Drosophila tracheal progenitor study does not establish effects of repeated fractional skin injury, fibroblasts or basal keratinocytes, collagen accumulation, migration, dermal or epidermal repair, nerve organization, SPV_9, or prevention of polyploidization.

S8Contradicts itAbstract only

Collagen and fibronectin synthesis by trisomic and triploid fibroblasts from human spontaneous abortuses. · Molecular & general genetics : MGG · 1987

“It was demonstrated that the level of fibronectin and collagen production in fibroblasts with trisomy 7, trisomy 9, and triploidy was reduced as compared with diploid cells.”

Does not settle: This abstract does not assess repeated fractional skin injury, endoreduplication without cell division, keratinocytes, migration, tissue repair, dermal organization, nerve endings, or SPV_9.

S10Background

Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing. · Diabetes · 2021

“The in vitro data further confirmed that LAMA3 siRNA significantly abolished the enhanced cell adhesion, migration, and proliferation by Dock5 transient transfection”

Does not settle: Источник не изучает повторные фракционные повреждения, удвоение генома без деления, полиплоидию, фибробласты, размеры клеток, организацию дермы вокруг нервных окончаний или SPV_9. Он также не устанавливает, что накопление коллагена сочетается с замедленным ремонтом по описанному механизму.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does repeated treatment of tiny skin areas deplete repair capacity even when increases?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Ускоряет ли повторное истощение , несмотря на рост , если после одинаковой бытовой нагрузки восстановление , прочности и чувствительности замедляется от цикла к циклу?

What this question is asking

The question concerns whether repeated skin treatment preserves the ability to recover from everyday stress or gradually wears that ability down. It asks whether , which acts on small areas within the treated skin, accelerates loss of repair capacity if later treatment cycles are followed by slower recovery of the skin’s protective barrier, strength and sensitivity after the same everyday stress. It assumes that can increase alongside this functional decline, but that combination is not established by the supplied evidence. The relevant comparison is recovery after successive cycles versus earlier cycles and skin receiving fewer or no treatments; the stated longer-term requirement is recovery as fast as in young skin, with acceptable safety, for at least 10 years.

What the terms mean
Fractional treatment
Treatment delivered to small areas within a larger skin region. The supplied sources discuss laser approaches and also a comparison involving radiofrequency; the input does not identify one precise treatment method or schedule for the proposed question.
Fractional laser treatment and microscopic treatment zones
Laser treatment uses light to act on tissue. S3 calls the small wounds created by its fractional approach microscopic treatment zones; these are the local injuries from which healing follows.
Radiofrequency treatment
A treatment category using energy from radiofrequency electrical signals. It appears as a comparator in S4, but the supplied quotation does not establish its effects on repeated functional recovery.
Treatment cycle
One treatment episode and its subsequent recovery period in the question’s repeated sequence. Multiple passes during one procedure do not by themselves establish multiple cycles separated by recovery.
Regenerative reserve or repair capacity
The proposed remaining ability of skin to repair damage over repeated challenges. The input does not define a directly measured quantity or a threshold at which this reserve counts as depleted.
Collagen
A structural protein that helps give skin support and strength and also forms part of scar tissue. Its amount and its organization are different properties; the supplied findings do not establish that either alone measures recovery capacity.
Skin barrier
The skin’s protective function at its surface. Barrier recovery means restoration of that protection after disruption, rather than simply a change in appearance.
Skin strength
The skin’s ability to withstand physical forces without damage. The input does not specify how this would be measured after everyday stress.
Skin sensitivity
The skin’s ability to register sensation. The input does not specify which sensations or measurements would count as recovery.
Fibroblast activation
Increased activity in cells that produce and other supporting material in skin. S9 reports signs of this activity, which is distinct from demonstrating increased long-term repair capacity.
Fibrosis
Accumulation of scar-like supporting tissue. The pipeline raises it as a possible consequence of repeated stimulation, but the supplied evidence does not establish that consequence in the proposed setting.
Carbon dioxide laser
A laser named for the gas used to generate its treatment light. Sources describing this laser concern particular treatment settings and do not establish the effects of every fractional method.
Low-intensity green laser treatment
An additional light treatment used after exposure in S10. Its reported effect cannot be treated as the effect of alone.
Skin graft
Skin moved to cover another area of the body. S2 includes treatment of these areas as well as burn scars, which differs from treatment aimed at restoring youthful function in middle-aged skin.
Depressed acne scars
Indented scars left after acne. S8 concerns these scars, rather than recovery of otherwise unspecified middle-aged skin after everyday stress.
Hypertrophic and keloid scars
Two forms of raised scarring: hypertrophic scars remain within the original injury area, while keloid scars extend beyond it. S5 addresses treatment effectiveness for these conditions.
What the question takes for granted
Premise only partly supported
can increase after while recovery of the , strength and sensitivity after identical everyday stress slows from cycle to cycle, potentially indicating depletion of .

is a structural protein in skin, while means the proposed capacity to keep repairing damage over repeated challenges. The question entertains a mismatch in which more structural material accompanies progressively poorer recovery of protection, strength and sensation. That mismatch would make increased an insufficient sign that repeated treatment preserves youthful function.

S8 describes stimulation of fibers, and S9 reports reorganization and signs of activation in -producing cells. These support a narrower premise that can affect , not the full claim that increases while functional recovery deteriorates across cycles. None of the supplied sources establishes that deterioration or identifies depletion of repair capacity as its cause. The supplied input labels earlier pipeline nodes as allowing depletion and , but provides no source evidence establishing those claims.S8S9

The same question asked without the part nothing read establishes:

  • Does repeated fractional skin treatment change recovery of protection, strength and sensitivity after identical everyday stress, and how do those changes relate to ?
  • Does repeated fractional skin treatment preserve recovery as fast as in young skin and acceptable safety for at least 10 years?
What turns on the answer
  • Repeated treatment depletes repair capacity Under this conditional outcome, successive treatments reduce the skin’s remaining ability to repair itself, so the same later stress is followed by slower recovery. If also increases, that increase would coexist with declining function and would not establish lasting restoration to a youthful condition.
  • Repeated treatment preserves repair capacity Under this conditional outcome, successive treatments leave the ability to recover intact despite repeated exposure. changes could then coexist with preserved function, although the separate requirement for acceptable safety over at least 10 years would still need to be established.
  • Recovery slows, but depletion is not established Under this conditional outcome, slower recovery demonstrates a functional change without identifying why it occurs. Calling that change depletion of repair capacity would go beyond the evidence, even if increased were documented at the same time.
Why it matters

The proposed concern follows a sequence: treatment affects small areas of skin, healing follows, and the skin must still recover from later everyday stress. A source describes treatment as creating small wounds, while other sources describe production or reorganization after treatment; these findings concern different parts of that sequence [S3, S8, S9]. If increases while recovery becomes slower, counting alone would miss the functional deterioration described in the question. Conversely, treating slower recovery as proof that repair capacity has been exhausted would assign a cause that the supplied sources have not established.

What is already established

RL-3 улучшает отдельные показатели; узлы RL-1 и RL-2 допускают истощение резерва и при повторной стимуляции.

What would have to be true

Повторное лечение сохраняет молодую скорость функционального восстановления и приемлемую безопасность на протяжении минимум 10 лет.

What is missing

Рост может сопровождаться ухудшением восстановления после последующих нагрузок; направленность накопленного эффекта требует прямой проверки.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Повторные переводят выжившие и часть в последовательные циклы . Возникают крупные с высокой , но сниженной способностью к и . Поэтому накапливается одновременно с замедлением функционального ремонта. Увеличение размеров клеток нарушает восстановление и организацию вокруг растущих . Носителем накопленного изменения служат и геометрия тех же . Предотвращение повторной должно стабилизировать , даже если прирост уменьшится.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В отслеживаемых увеличение должно предшествовать замедлению восстановления после следующей нагрузки. В предотвращение повторного должно сохранять скорость восстановления , и при сопоставимых исходном повреждении, и числе клеток. Пространственно правильная подача или восстановление нервной активности без изменения не должны полностью устранять дефект. Отсутствие накопленной либо сохранение функционального ухудшения после ее предотвращения опровергнет гипотезу.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable temporal ordering, functional outcomes under stated comparable conditions, incomplete rescue, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

, и наблюдение за позволяют отличить устойчивую от обычной и . требует отдельной разработки в : неспецифическое торможение не будет достаточной проверкой. Восстановление чувствительности необходимо оценивать в и затем у человека.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В отслеживаемых увеличение должно предшествовать замедлению восстановления после следующей нагрузки. В предотвращение повторного должно сохранять скорость восстановления , и при сопоставимых исходном повреждении, и числе клеток. Пространственно правильная подача или восстановление нервной активности без изменения не должны полностью устранять дефект. Отсутствие накопленной либо сохранение функционального ухудшения после ее предотвращения опровергнет гипотезу.

  • What would separate them

    Loss of positional signals may slow skin repair by disrupting tissue organization predicts: При одинаковых площади и глубине повреждения, числе выживших клеток и количестве восстановление должно зависеть от сохранности конкретных сочетаний . В модели повторного повреждения пространственно правильное восстановление этих сигналов должно ускорять ремонт; те же молекулы в тех же суммарных количествах, но с перемешанным расположением, такого эффекта не дадут. Предварительно измеренная должна предсказывать ухудшение на новых образцах. Отсутствие преимущества правильного расположения или независимости предсказания от общей потери ткани опровергнет механизм.

  • What would separate them

    Repeated fractional treatment may slow skin recovery by injuring regrowing sensory axons predicts: Ухудшению барьерного и механического восстановления должно предшествовать увеличение времени и снижение . Селективное сохранение при сопоставимом повреждении других тканей должно предотвращать ухудшение всех трех направлений. В восстановление сигнала при сохраняющейся должно улучшать часть барьерного и , но оставлять ; восстановление самих должно устранять и его. Нормальная и отсутствие эффекта ее селективного сохранения опровергнут эту гипотезу.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

В дрозофилы и мыши увеличение компенсировало потерю клеток, поддерживая количество геномного материала ткани. Это показывает возможность сохранения массы и без соответствующего восстановления числа клеток. Для кожи человека после фракционных процедур такой механизм не установлен. [Losick et al., 2016](https://pmc.ncbi.nlm.nih.gov/articles/PMC4784922/).

Subfield revised

и ; учебный раздел «Заживление кожи после ». Пересмотра потребует модель, связывающая накопленный преимущественно с продуктивным обновлением клеток: основным источником окажется увеличение числа внутри крупных клеток, создающее последующий функциональный предел.

Testable surprise

Предотвращение уменьшает прирост , но сохраняет восстановление всех трех функциональных направлений после повторных нагрузок. Наиболее выраженный коллагеновый ответ оказывается связан с наихудшей последующей восстанавливаемостью.

Why this is not the mainstream account

Поиск сочетаний / и fractional skin/ не выявил работы, утверждающей именно этот механизм накопленного ухудшения. Однако при ремонте тканей уже обсуждается в обзорах. Новизна относится только к заявленной причинной роли при повторном ; отсутствие аналогичной гипотезы во всей литературе не доказано, поэтому строгий статус остается предварительным.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.